Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture

      CEO to be named soon for Berkshire, Amazon, JPMorgan healthcare venture

      Ruby Khatun Khatun11 Jun 2018 9:45 AM IST
      Berkshire Hathaway Inc, Amazon.com Inc and JPMorgan Chase & Co within the next two weeks will likely name a chief executive for their joint...
      Bayer completes acquisition of Monsanto

      Bayer completes acquisition of Monsanto

      Ruby Khatun Khatun11 Jun 2018 9:30 AM IST
      LEVERKUSEN/NEW DELHI: German chemical and pharma major Bayer AG announced the completion of the $63 billion mega-deal to acquire US-based biotech...
      Philip Morris plans to target Indian smokers with iQOS device - sources

      Philip Morris plans to target Indian smokers with iQOS device - sources

      Ruby Khatun Khatun11 Jun 2018 9:18 AM IST
      New Delhi: Philip Morris International Inc is planning to launch its iQOS smoking device in India, four sources familiar with the matter told Reuters,...
      Apple bags patent for blood pressure monitor design

      Apple bags patent for blood pressure monitor design

      Ruby Khatun Khatun10 Jun 2018 11:34 AM IST
      California: Apple has patented a design for a device that would help monitor blood pressure more seamlessly.The design is for a wearable blood...
      Cipla partners with Eli Lilly to market diabetes drug Basaglar in India

      Cipla partners with Eli Lilly to market diabetes drug Basaglar in India

      Ruby Khatun Khatun10 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Cipla said it has partnered with Eli Lilly to market and distribute Lilly's insulin glargine injection, Basaglar, in...
      Aurobindo Pharma gets USFDA nod for heartburn drug

      Aurobindo Pharma gets USFDA nod for heartburn drug

      Ruby Khatun Khatun10 Jun 2018 10:15 AM IST
      New Delhi: Aurobindo Pharma said it has received final approval from the US health regulator to manufacture Omeprazole delayed-release tablets, used...
      FDI in India rises to 61.96 billion dollar in 2017-18: Government

      FDI in India rises to 61.96 billion dollar in 2017-18: Government

      Ruby Khatun Khatun10 Jun 2018 10:00 AM IST
      New Delhi: Foreign direct investment (FDI) in India increased by about 3 percent to $61.96 billion in 2017-18 on account of steps taken by the...
      Pfizer wins appeal against UK fine for epilepsy drug price hike

      Pfizer wins appeal against UK fine for epilepsy drug price hike

      Ruby Khatun Khatun10 Jun 2018 9:45 AM IST
      LONDON: Pfizer Inc and Flynn Pharma won an appeal against fines totaling nearly 90 million pounds ($120 million) imposed in 2016 for ramping up the...
      Johnson and Johnson gets 2.7 billion dollar offer for sterilization unit from Fortive

      Johnson and Johnson gets 2.7 billion dollar offer for sterilization unit from Fortive

      Ruby Khatun Khatun10 Jun 2018 9:30 AM IST
      Johnson and Johnson said that Fortive Corp had offered to buy its medical sterilization unit for about $2.7 billion in cash.J&J has been reviewing...
      Refix ceiling price of Zydus rosuvastatin 20mg plus clopidogrel 75mg capsule:  DoP orders NPPA

      Refix ceiling price of Zydus rosuvastatin 20mg plus clopidogrel 75mg capsule: DoP orders NPPA

      Ruby Khatun Khatun9 Jun 2018 1:41 PM IST
      New Delhi: The Department of Pharmaceuticals (DoP) has accepted the Zydus Healthcare’s review petition against price fixation of “Rosuvastatin 20mg +...
      NATCO Pharma launches generic Posaconazole injection in India

      NATCO Pharma launches generic Posaconazole injection in India

      Ruby Khatun Khatun9 Jun 2018 10:45 AM IST
      Hyderabad: NATCO Pharma Limited announced that it has launched a generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand...
      USFDA for voluntary action by Sun Pharmas on Halol plant observations

      USFDA for voluntary action by Sun Pharma's on Halol plant observations

      Ruby Khatun Khatun9 Jun 2018 10:30 AM IST
      New Delhi: US health regulator USFDA has said it found objectionable conditions at Sun Pharmaceutical Industries' Halol plant in Gujarat but did not...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok